Skip to content
A jug of generic glyphosate weed killer beside a bottle of purple marking dye, a funnel and a hand pump sprayer

Health

Edge of Frame · Left

Judge approves Bayer's $7.25 billion Roundup settlement over cancer claims

The deal pays lymphoma patients over as long as 21 years and binds many who could fall ill later, after the Supreme Court weakened such lawsuits.

Published 7 min read

A generic weed killer made with glyphosate, the same active ingredient as Roundup, set out with marking dye and a sprayer. Photo, Oct. 2023: Slknight / Wikimedia Commons / CC BY-SA 4.0

Who covered this

How we flag these

The short version

  • A Missouri judge on Friday approved Bayer's settlement of up to $7.25 billion over claims that its Roundup weedkiller causes cancer.
  • It pays people with non-Hodgkin lymphoma over as long as 21 years and covers many who may get sick in the future.
  • Objecting lawyers could appeal, and the EPA expects to finish a new review of glyphosate's health risks in late 2026.
Documents in this story · 5
  • RulingMonsanto Co. v. Durnell, No. 24-1068, opinionSupreme Court of the United States · PDF · June 25, 2026Original Archived
  • RulingAnnouncement of the court-authorized notice of the proposed class settlement in King v. Monsanto Co., PR Newswire, March 9, 2026Class counsel (Seeger Weiss and others) · Web pageOpen Archived
  • RecordStatement on objections and removal of the Missouri class caseKeller Postman · Web page · May 22, 2026Open Archived
  • RecordGlyphosateU.S. EPA · Web pageOpen Archived
  • RecordIARC news on glyphosateInternational Agency for Research on Cancer · Web pageOpen Archived

A Missouri judge on Friday approved Bayer's Roundup settlement, a deal worth up to $7.25 billion over claims that the weedkiller causes cancer. Judge Timothy Boyer of a St. Louis state court found the deal "fair, reasonable, and adequate."

The ruling could close most of a fight that has dogged Bayer since it bought Monsanto, Roundup's maker, in 2018. It also does something lawsuits can't: it settles claims for people who are not sick yet. That reach is why some cancer patients' lawyers fought it, and why the company wanted it.

Why it matters to you

If you used Roundup at home or at work, this deal may already cover you. The class takes in farmers, landscapers, gardeners and others exposed in the U.S. before Feb. 17, 2026, according to class counsel's announcement of the court-approved notice. It includes people who have not been diagnosed with anything.

The deadline to leave the class and keep your right to sue on your own was June 4. For people who stayed in, a future diagnosis of non-Hodgkin lymphoma, a blood cancer, would lead to a claim under the settlement rather than a lawsuit. Average awards run from about $10,000 to $165,000, depending on how you used the product, your age at diagnosis and how severe the illness is.

Who the Bayer Roundup settlement covers, and how it pays

Bayer will pay into a fund every year for up to 21 years. The company faces about 65,000 claims in state and federal courts, and the deal aims to resolve nearly all current and future U.S. cases. It leaves out about 200 cases still moving through a group of federal lawsuits, where Bayer says the Supreme Court ruling gives it strong defenses.

The settlement also sets aside $600 million for lawyers' fees, The National Desk reported. Bayer has already removed glyphosate, Roundup's key ingredient, from the version sold to home users.

Boyer rejected objections that the awards were too low because people who settled earlier got more. He also warned that a delay could leave sick people, including some whose cancer is terminal, waiting "an indeterminate number of years." The decision can still be appealed.

How a Supreme Court ruling changed the odds

This is Bayer's second try at settling future claims. In 2020 it paid about $10 billion to settle most of the cases then pending, but a separate deal for future claims never won court approval. Bayer's share price has fallen 46% since the Monsanto purchase.

The new deal was announced in February and won preliminary approval in March. Then, in June, the Supreme Court ruled 7-2 for Monsanto in the case of John Durnell, a Missouri man who blamed Roundup for his lymphoma. The ruling threw out his $1.25 million jury award.

The opinion explains why that mattered so much. The Environmental Protection Agency approved Roundup's label without a cancer warning, and federal law requires Monsanto to use the label the EPA approved. A state claim demanding a warning would add a rule federal law does not, so it is preempted, or overridden. Justice Ketanji Brown Jackson, joined by Justice Neil Gorsuch, dissented.

That puts the EPA's judgment at the center of future Roundup warning claims. The agency concluded in 2017 that glyphosate is not likely to cause cancer in humans. In 2015, the World Health Organization's cancer agency classified it as probably carcinogenic to humans, citing limited evidence in people. The EPA says the two reviews differed in scope: the WHO agency asks whether a chemical can cause cancer at all, while the EPA weighs real-world exposure.

Boyer cited the Supreme Court ruling in his approval and said that, even without it, Monsanto had won most of the related cases. Mounting legal costs had led Bayer to consider pulling Roundup from U.S. farm markets.

fair, reasonable, and adequate

Judge Timothy Boyer, St. Louis, on the Roundup settlement, Nov. 20 (BBC)

What we don't know yet

Whether the objectors will appeal, and how long an appeal would hold up payments, is still open. Their lawyers did not immediately respond to requests for comment from Reuters on Friday, and we found no public response from them as of 5:50 a.m. ET Saturday.

Neither the politics nor the science is settled. Pesticides have become a cause for Health Secretary Robert F. Kennedy Jr.'s "Make America Healthy Again" movement, whose supporters cited them this month when they opposed the White House's pick to run the FDA. The Trump administration, though, backed Monsanto at the Supreme Court. The EPA is updating its assessment of glyphosate's health risks, with completion expected in late 2026. Under the Supreme Court's reasoning, a new finding there could shape what any future label must say.

The case each side makes

The case for the deal

For Bayer, the approval is about limiting its legal risk. Its chief executive, Bill Anderson, said in a written statement that it was "a decisive milestone in the company's strategy to mitigate the risks" of current and future Roundup suits. The company denies that Roundup causes cancer and has said decades of studies show glyphosate is safe.

Plaintiffs' lawyers who support the deal say it guarantees money to sick people when lawsuits look more uncertain than ever. Christopher Seeger, a court-appointed lawyer for cancer patients, said the order "delivers guaranteed compensation to Roundup cancer victims." He has said the Durnell ruling narrowed victims' ability to press their claims in court.

The case against it

Lawyers for some cancer patients say the deal pays too little and that its terms are too restrictive. Ashley Keller, who represented Durnell at the Supreme Court, objected for 10 clients in May. He said the deal was "extinguishing the rights of tens of thousands of cancer victims," in AP's report.

His firm's statement that month said the average gross award was under $60,000 and that home users' awards were capped at $40,000. It objected to a $675 million fee request and said the terms "rush and impede victims' free choice to leave the class." Keller tried to move the case to federal court. Other opponents said the deal was built to trap people who would rather sue.

How coverage differs

For readers of left-leaning outlets, a deal that settles cancer claims for people not yet sick stayed at the edge of the frame: beyond AP's own wire story, the left-leaning outlets we read only reprinted wire copy.

If you read the left 1 of 13 outlets

Wire copy was all you had.

If you read the center 4 of 9 outlets

Each outlet picked its own angle.

If you read the right 3 of 12 outlets

Fees and an appeal reached you.

Sources

This article was produced by AI under our Editorial Standards. Corrections are reviewed before they go live.

Challenge this article

How coverage differs

Free with a Fair Witness account

See how left, center and right covered this story

A free account shows where the coverage agrees and where it splits, what each side played up and played down, and, when one side's outlets missed a story, who missed it.

Share this story

Challenge this article

Found a factual error? Send us published evidence. We review every submission and correct errors in public.

Keep reading

The newest stories in Health, then the rest of the site.

Latest

New stories and updates, newest first. Times are Eastern.

All updates
  1. Nov 22

    12:13 AMTop story U.S.

    ICE arrests two passengers on a Seattle airport jet bridge as they board a flight

    Washington's governor said he believes the masked officers broke a new state law, but that law's only penalty is a lawsuit by the people detained.

  2. Nov 21

    6:12 PMNew Economy

    Trump says he would work with Democrats on a 10% credit card interest rate cap

    The president and Sen. Elizabeth Warren now back a cap that banks and some Republican senators oppose, and no bill has moved yet.

  3. Nov 21

    5:19 PMUpdated Health

    US loses measles elimination status after 26 years, PAHO says

    The finding that measles spreads here again means the U.S. must now stop the spread for a full year to win the status back.

    Spin Meter: how each side framed it · 4/5
  4. Nov 21

    5:17 PMUpdated World

    Mexico captures 'El Chapo Isidro,' an FBI Ten Most Wanted fugitive, in Sinaloa raid

    U.S. prosecutors charged him in 2012, and Mexico has not yet said whether it will send him north to face those charges.

  5. Nov 21

    2:55 PMUpdated U.S.

    House Democrats seek Cantor Fitzgerald's Nvidia records in Lutnick probe

    The letter shows how the House's incoming Democratic chairs plan to test whether Lutnick's handling of Megaspeed was shaped by his family firm's Nvidia stake.

  6. Nov 21

    11:50 PMUpdated U.S.

    Trump orders federal contractors to check with White House before answering Congress

    The order gives the White House a say in what companies doing government work tell Congress, weeks before Democrats take charge and start investigating.

  7. Nov 21

    11:14 PMUpdated Science

    COP31 climate talks run into overtime after draft drops fossil fuels

    Whether the year's climate deal names oil, gas and coal at all now rests on a consensus rule that lets one country block it.

    Out of Frame · Right

  8. Nov 21

    11:12 PMUpdated Science

    BepiColombo enters Mercury orbit, only the second mission to circle the planet

    After an eight-year trip and a year's delay, two orbiters are set to study a planet that only NASA had circled before.

  9. Nov 21

    8:52 PMUpdated U.S.

    Storm that flooded Florida heads up the East Coast as Thanksgiving week nears

    Wind, rain and coastal flooding could reach the Carolinas Saturday and New England by Sunday night, and forecasters see another East Coast storm around Thanksgiving.

  10. Nov 21

    8:37 PMUpdated U.S.

    Cornyn blocks Elliot Gaiser, Trump's pick for a Dallas federal court seat

    A Texas senator's veto can stop a lifetime judgeship, and Republicans have until Jan. 3 to fill the seat before Democrats run the Senate.

  11. Nov 21

    8:36 PMUpdated World

    Russian missile crashes in Poland as strikes hit three Kyiv bridges

    Poland called the crash a likely intentional provocation during allied drills, and NATO's treaty leaves each ally to decide how to respond.

    Edge of Frame · Right

  12. Nov 21

    8:19 PMUpdated Technology

    FBI investigating apparent breach of its national crime database, CNN and NBC report

    Police across the country run warrant and gun checks on the system, and it is the second federal breach reported in a day.

  13. Nov 21

    8:18 PMUpdated U.S.

    Katie Zacharia faces California State Bar investigation over lawyer claims

    The case tests whether California's law making it a crime to claim you can practice law without a license reaches a TV commentator.

The Fair Witness Daily

Get each morning's Spin Meter in your inbox

The Daily leads with the Spin Meter, then the day's explainers. A free account also unlocks every Spin Meter on the site.

Check your inbox to confirm your subscription.

Free. Unsubscribe anytime. Already a member? Sign in